tradingkey.logo

Esperion Reports $156 To $160 Million In Preliminary Full-Year 2025 U.S. Net Product Sales

ReutersJan 11, 2026 11:04 PM

- Esperion Therapeutics Inc ESPR.O:

  • ESPERION PROVIDES BUSINESS UPDATE AT 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

  • ESPERION THERAPEUTICS INC - REPORTS $156 TO $160 MILLION IN PRELIMINARYFULL-YEAR 2025 U.S. NET PRODUCT SALES

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI